Report Status: Final
CHAVES, MARCELO
Patient Information |
Specimen Information |
Client Information |
|
CHAVES, MARCELO DOB: 01/03/1970 AGE: 45 Gender: M Phone: NG Patient ID: P6490271 Health ID: 8573014054907036 |
Specimen: Requisition: Lab Ref #:
Collected: Received: Reported: |
TM663086M 0006502 3863669 07/29/2015 / 14:02 EDT 07/30/2015 / 05:45 EDT 08/05/2015 / 02:14 EDT |
Client #: 66007420 09SS999 CUNNINGHAM, RUTHANN ANALYTE PHYSICIAN GROUP Attn: NORTH FLORIDA 328 S JEFFERSON ST STE 770 CHICAGO, IL 60661-5646 |
Test (Req #3863669) |
Value |
Range |
Result |
Test Date |
Results Date |
HIV 1
RNA |
Not
Detected |
Not
Detected |
Negative |
07/29/2015 |
08/05/2015 |
Chlamydia |
NOT
DETECTED |
NOT
DETECTED |
Negative |
07/29/2015 |
08/05/2015 |
Hepatitis
B |
NON-REACTIVE |
NON-REACTIVE |
Negative |
07/29/2015 |
08/05/2015 |
Hepatitis
C |
NON-REACTIVE |
NON-REACTIVE |
Negative |
07/29/2015 |
08/05/2015 |
Hepatitis
C Quantitative |
0.03 |
<1.00 |
Negative |
07/29/2015 |
08/05/2015 |
Gonorrhea |
NOT
DETECTED |
NOT
DETECTED |
Negative |
07/29/2015 |
08/05/2015 |
Herpes
Simplex Virus Type I |
<0.80 |
<0.90 |
Negative |
07/29/2015 |
08/05/2015 |
Herpes
Simplex Virus Type II |
<0.70 |
<0.90 |
Negative |
07/29/2015 |
08/05/2015 |
HIV-1/2
4TH GEN |
NON-REACTIVE |
NON-REACTIVE |
Negative |
07/29/2015 |
08/05/2015 |
Syphilis |
NON-REACTIVE |
NON-REACTIVE |
Negative |
07/29/2015 |
08/05/2015 |
Test Name In Range Out Of Range Reference Range Lab
HEPATITIS B SURFACE TP
ANTIGEN W/REFL CONFIRM
HEPATITIS B SURFACE
ANTIGEN NON-REACTIVE NON-REACTIVE
HEPATITIS C ANTIBODY NON-REACTIVE NON-REACTIVE TP
SIGNAL TO CUT-OFF 0.03 <1.00
HSV 1/2 IGG,TYPE SPECIFIC TP
AB HERPESELECT
HSV 1 IGG TYPE SPECIFIC
AB <0.80
H
HSV 2 IGG TYPE SPECIFIC
AB <0.70 H
Value Interpretation
----- --------------
<0.90 Negative
0.90-1.10 Equivocal
>1.10 Positive
This assay utilizes recombinant type-specific antigens
to differentiate HSV-1 from HSV-2 infections. A
positive result cannot distinguish between recent and
past infection. If recent HSV infection is suspected
but the results are negative or equivocal, the assay
should be repeated in 4-6 weeks. The performance
characteristics of the assay have not been established
for pediatric populations, immunocompromised patients,
or neonatal screening.
CHLAMYDIA/N. GONORRHOEAE TP
RNA, TMA
CHLAMYDIA TRACHOMATIS
RNA, TMA NOT DETECTED NOT DETECTED
NEISSERIA GONORRHOEAE
RNA, TMA NOT DETECTED NOT DETECTED
See Endnote 1
RPR (DX) W/REFL TITER AND TP
CONFIRMATORY TESTING NON-REACTIVE NON-REACTIVE
Endnote 1 This test was performed using the APTIMA COMBO2 Assay
(Gen-Probe Inc.).
The analytical performance characteristics of this
assay, when used to test SurePath specimens have
been determined by Quest Diagnostics.
CLIENT SERVICES: 866.697.8378 SPECIMEN: TM663086M PAGE 1 OF 2
Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics.
Report Status: Final
CHAVES, MARCELO
|
Patient Information |
Specimen Information |
Client Information |
|||||
|
CHAVES, MARCELO DOB: 01/03/1970 AGE: 45 Gender: M Patient ID: P6490271 Health ID: 8573014054907036 |
Specimen: TM663086M Collected: 07/29/2015 / 14:02 EDT Received: 07/30/2015 / 05:45 EDT Reported: 08/05/2015 / 02:14 EDT |
Client #: 66007420 CUNNINGHAM, RUTHANN |
|||||
Infectious Diseases |
|
|
|
|||||
Test Name Result |
Reference Range |
Lab |
|
|||||
HIV 1 RNA, QL TMA |
Not Detected |
Not Detected |
AMD |
|
||||
This test was performed using the APTIMA(R) HIV-RNA Qualitative Assay (Gen-Probe).
|
|
|
||||||
HIV 1/2 ANTIGEN/ANTIBODY,FOURTH GENERATION W/RFL |
|
|
||||||
HIV 1/2 ANTIGEN/ANTIBODY, FOURTH GENERATION W/RFL |
TP |
|
||||||
HIV AG/AB, 4TH GEN |
NON-REACTIVE |
NON-REACTIVE |
|
|
||||
A Nonreactive HIV Ag/Ab result does not exclude HIV infection since the time frame for seroconversion is variable. If acute HIV infection is suspected, a HIV-1 RNA Qualitative TMA test is recommended. PLEASE NOTE: This information has been disclosed to you from records whose confidentiality may be protected by state law. If your state requires such protection, then the state law prohibits you from making any further disclosure of the information without the specific written consent of the person to whom it pertains, or as otherwise permitted by law. A general authorization for the release of medical or other information is NOT sufficient for this purpose. The performance of this assay has not been clinically validated in patients less than 2 years old. For additional information please refer to http://education.questdiagnostics.com/faq/FAQ106 (This link is being provided for informational/ educational purposes only.)
|
|
|
||||||
Physician Comments: |
|
|
||||||
PERFORMING SITE:
AMD QUEST DIAGNOSTICS/NICHOLS CHANTILLY, 14225 NEWBROOK DRIVE, CHANTILLY, VA 20151-2228 Laboratory Director: PATRICK W. MASON,MD,PHD, CLIA: 49D0221801
TP QUEST DIAGNOSTICS-TAMPA, 4225 E. FOWLER AVE,
TAMPA, FL 33617-2026 Laboratory Director: GLEN L HORTIN,MD,PHD,
CLIA: 10D0291120
Quest,
Quest Diagnostics, the associated logo and all associated Quest Diagnostics
marks are the trademarks of Quest Diagnostics.